> Is it to the price level (e.g. under $1K) where an individual patient could pay a lab to sequence their own virus sample? Sure. It'll run under $50 in bulk.

> Is it to the price level (e.g. under $1K) where an individual patient could pay a lab to sequence their own virus sample? Sure. It'll run under $50 in bulk. Less, but not that much less, if you're only interested in sequencing the spike. > How about the cost of sequencing one drop of the vaccine vial they received, as a quality control sample of the distribution supply chain? This isn't a useful quality check. A negative result implicates your field assay rather than manufacturing.